The DOI matches its Crossref record; 110 of the 111 references it cites were found in a registry or an index.
Type-2 Diabetes Mellitus and Cardiovascular Disease
Abstract
The global prevalence of diabetes has risen in adults from 4.7% in 1980 to 8.5% in 2014. 90-95% of adults with diabetes have Type 2 diabetes (T2D). This paper focuses on the diagnosis and treatment of T2D patients who have or are at risk for cardiovascular disease. Hyperglycemia, insulin resistance and excess fatty acids increase oxidative stress, disrupt protein kinase C signaling and increase advanced glycation end-products that result in vascular inflammation, vasoconstriction, thrombosis and atherogenesis. Intensive T2D treatment produces a ≥10% risk reduction in major macrovascular and microvascular events. Glucose-lowering therapies must be individualized. Metformin is an optimal drug for monotherapy. If hemoglobin A1c is not at goal, a sodium-glucose cotransporter-2 inhibitor or a dipeptidyl peptidase-4 inhibitor should be considered for therapy with metformin. Coronary angioplasty/stenting is recommended for diabetic patients with acute myocardial infarctions. Coronary artery bypass grafting is recommended for symptomatic diabetic patients with multivessel disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cardiovascular diseases, involving coronary heart disease, peripheral vascular disease and cerebrovascular disease, are the primary contributors of death and disability in diabetic people (112).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [112]
Citations
Cites
1 retracted
Reduced dietary salt for the prevention of cardiovascular disease
Taylor, R. S., Ashton, K. E., Moxham, T., Hooper, L., & Ebrahim, S. B. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009217.pub2 · Cited by 311
RetractedMcDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Flagged first, then by citations
1 of the 111 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Herman W , KalyaniR, CherringtonA . American diabetes association standards of medical care in diabetes . Diabetes Care40 ( Suppl. 1 ), S1 – S132 ( 2017 ).
Cited by
Sorted by citations
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Henning, R. J. (2021) · Europe PMC (PubMed Central) · Cited by 209
Self-citationA Role for Advanced Glycation End Products in Molecular Ageing
Zgutka, K., Tkacz, M., Tomasiak, P., & Tarnowski, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129881 · Cited by 158
NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
Góra, I. M., Ciechanowska, A., & Ładyżyński, P. (2021) · Cells · doi:10.3390/cells10020314 · Cited by 159
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
Kitamura, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043219 · Cited by 146
Siam, N. H., Snigdha, N. N., Tabasumma, N., & Parvin, I. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2512436 · Cited by 171
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Huang, K., Luo, X., Liao, B., Li, G., & Feng, J. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01816-5 · Cited by 117
Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
Barbu, E., Popescu, M.-R., Popescu, A.-C., & Balanescu, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020963 · Cited by 96
Ansari, P., Khan, J. T., Chowdhury, S., Reberio, A. D., Kumar, S., Seidel, V., Abdel‐Wahab, Y. H. A., & Flatt, P. R. (2024) · Nutrients · doi:10.3390/nu16213709 · Cited by 115
Dastani, M., Rahimi, H. R., Askari, V. R., Jaafari, M. R., Jarahi, L., Yadollahi, A., & Rahimi, V. B. (2022) · BioFactors · doi:10.1002/biof.1874 · Cited by 84
The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
Porcuna, J., Mínguez-Martínez, J., & Ricote, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910573 · Cited by 82
Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits
Zawada, A. E., Machowiak, A., Rychter, A. M., Ratajczak, A. E., Szymczak‐Tomczak, A., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2022) · Nutrients · doi:10.3390/nu14193982 · Cited by 87
The Wnt Signaling Pathway in Diabetic Nephropathy
Wang, H., Zhang, R., Wu, X., Chen, Y., Ji, W., Wang, J., Zhang, Y., Xia, Y., Tang, Y., & Yuan, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701547 · Cited by 79
Influence of omega n-6/n-3 ratio on cardiovascular disease and nutritional interventions
Bishehkolaei, M., & Pathak, Y. V. (2024) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2024.200275 · Cited by 75
Circular RNAs in diabetes mellitus and its complications
Fan, W., Pang, H., Xie, Z., Huang, G., & Zhou, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.885650 · Cited by 84
The Footprint of Kynurenine Pathway in Cardiovascular Diseases
Ala, M., & Eftekhar, S. P. (2022) · International Journal of Tryptophan Research · doi:10.1177/11786469221096643 · Cited by 63
Huemer, J. C., Wagner, S. K., & Sim, D. A. (2020) · Clinical ophthalmology · doi:10.2147/opth.s261629 · Cited by 63
The Role of Omega- 3 Polyunsaturated Fatty Acids in Diabetes Mellitus Management: A Narrative Review
Bayram, S. Ş., & Kızıltan, G. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00561-9 · Cited by 61
Su, S., Hung, Y., Huang, C., Shieh, Y., Chien, C., Chiang, C., Liu, J., Lu, C., Hsieh, C., Lin, C., et al. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0550-9 · Cited by 52
Huang, F., Zhao, R., Xia, M., & Shen, G. X. (2020) · Microorganisms · doi:10.3390/microorganisms8081238 · Cited by 52
Kikiowo, B., Ahmad, I., Alade, A. A., Ijatuyi, T. T., Iwaloye, O., & Patel, H. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2155699 · Cited by 51
AlAufi, N. S., Chan, Y. M., Waly, M. I., Chin, Y. S., Yusof, B. N. M., & Ahmad, N. (2022) · Nutrients · doi:10.3390/nu14132777 · Cited by 52
The Role of Lonp1 on Mitochondrial Functions during Cardiovascular and Muscular Diseases
Zanini, G., Selleri, V., Malerba, M., Solodka, K., Sinigaglia, G., Nasi, M., Mattioli, A. V., & Pinti, M. (2023) · Antioxidants · doi:10.3390/antiox12030598 · Cited by 50
Tian, M., Han, Y., Zhao, C., Liu, L., & Zhang, F. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00664-1 · Cited by 54
Garay‐Sevilla, M. E., Beeri, M. S., de la Maza, M. P., Armando Rojas, R., Salazar‐Villanea, S., & Uribarri, J. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000104 · Cited by 55
Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases
He, S., Jiang, H., Zhuo, C., & Jiang, W. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09656-z · Cited by 46
Su, X., He, J., Jianmei, C., Li, H., & Men, J. (2022) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12996 · Cited by 60
Wang, S., Li, L., Liu, T., Jiang, W., & Hu, X. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0136 · Cited by 46
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms
Muric, M. D., Zivkovic, V. I., Joksimović, J., Sretenovic, J. Z., Davidović, G., Simovic, S. M., Djoković, D., Muric, N. N., Bolevich, S., & Jakovljevic, V. L. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10079-9 · Cited by 46
C-Peptide as a Therapy for Type 1 Diabetes Mellitus
Washburn, R. L., Mueller, K., Kaur, G., Moreno, T., Moustaïd‐Moussa, N., Ramalingam, L., & Dufour, J. M. (2021) · Biomedicines · doi:10.3390/biomedicines9030270 · Cited by 44
Weight variability and cardiovascular outcomes: a systematic review and meta-analysis
Massey, R. J., Siddiqui, M. K., Pearson, E. R., & Dawed, A. Y. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01735-x · Cited by 42
Guan, W., & Wang, Q. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154938 · Cited by 43
Imbalzano, E., Ilardi, F., Orlando, L., Pintaudi, B., Savarese, G., & Rosano, G. M. C. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad019 · Cited by 40
The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
Jiang, Y., Shui, J., Zhang, B., Chin, J.-W., & Yue, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585487 · Cited by 43
Cui, X., Feng, J. B., Wei, T., Zhang, L., Lang, S., Yang, K., Yang, J., Liu, J., Sterr, M., Lickert, H., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05822-2 · Cited by 39
Ribeiro, M. M., Alvarenga, L., Coutinho‐Wolino, K. S., Nakao, L. S., Cardozo, L., & Mafra, D. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.034 · Cited by 38
Nagata, J. M., Vittinghoff, E., Gabriel, K. P., Garber, A. K., Moran, A. E., Rana, J. S., Reis, J. P., Sidney, S. S., & Bibbins-Domingo, K. B. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-104231 · Cited by 38
Lolok, N., Sumiwi, S. A., Muhtadi, A., Susilawati, Y., Hendriani, R., Ramadhan, D. S. F., Levita, J., & Sahidin, I. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1894981 · Cited by 37
Treatment Response to SGLT2 Inhibitors: From Clinical Characteristics to Genetic Variations
Klen, J., & Dolžan, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189800 · Cited by 45
Hua, Y., Zhang, Y., Gong, W., Ding, Y., Shen, J., Li, H., Chen, Y., & Meng, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186699 · Cited by 36
Circular RNAs in metabolism and metabolic disorders
Zeng, Y.-Z., Zheng, Z., Liu, F., & Yi, G. (2021) · Obesity Reviews · doi:10.1111/obr.13220 · Cited by 40
Mirshafiei, H., Darroudi, S., Ghayour‐Mobarhan, M., Esmaily, H., AkbariRad, M., Mouhebati, M., & Ferns, G. A. (2022) · BioFactors · doi:10.1002/biof.1816 · Cited by 36
MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats
Li, S., Wang, M., Ma, J., Pang, X., Yuan, J., Pan, Y., Fu, Y., & Laher, I. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.812032 · Cited by 36
Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34
Molecular Mechanisms of Type 2 Diabetes-Related Heart Disease and Therapeutic Insights
Giraldo, G. C., Román-Gonzaléz, A., Cañas, F., & García, A. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104548 · Cited by 38
The relationship between HMGB1 and autophagy in the pathogenesis of diabetes and its complications
Yang, K., Cao, F., Wang, W., Tian, Z., & Yang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1141516 · Cited by 34
Yavorov-Dayliev, D., Milagro, F. I., Ayo, J., Oneca, M., Goyache, I., Lópeź‐Yoldi, M., & Aranaz, P. (2023) · Diabetologia · doi:10.1007/s00125-023-05981-w · Cited by 37
Azhdari, M., & Hausen, A. Z. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107565 · Cited by 35
Feng, X., Wang, S., Yang, X., Lin, J. M., Man, W., Dong, Y., Zhang, Y., Zhao, Z., Wang, H., & Sun, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.628842 · Cited by 31
Jiménez‐Cortegana, C., Iglesias, P., Ribalta, J., Vilariño‐García, T., Montánez, L., Arrieta, F., Aguilar‐Diosdado, M., Durán, S., Obaya, J. C., Becerra, A., et al. (2021) · Nutrients · doi:10.3390/nu13114150 · Cited by 34
Guillén‐Guío, B., Lorenzo-Salazar, J. M., González‐Montelongo, R., Usera, A. D.-D., Marcelino-Rodríguez, I., Corrales, A., de León, A. C., Alonso, S., & Flores, C. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy190 · Cited by 30
Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
Shi, T., Kobara, H., Oura, K., & Masaki, T. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s274933 · Cited by 29
Urbanowicz, T. K., Michalak, M., Al-Imam, A., Olasińska‐Wiśniewska, A., Rodzki, M., Witkowska, A., Haneya, A., Buczkowski, P., Perek, B., & Jemielity, M. (2022) · Diagnostics · doi:10.3390/diagnostics12030634 · Cited by 31
Protein glycation in diabetes mellitus
Shin, A., Connolly, S. M., & Kabytaev, K. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.11.003 · Cited by 34
Risk factors for carotid plaque formation in type 2 diabetes mellitus
Chen, J., Li, W., Cao, J., Lu, Y., Wang, C., & Lu, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04836-7 · Cited by 27
Ding, X.-M., Zhang, X., Wei, X., Wu, R., Gu, Q., & Zhou, T. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c00547 · Cited by 27
Typiak, M., Kulesza, T., Rachubik, P., Rogacka, D., Audzeyenka, I., Angielski, S., Saleem, M., & Piwkowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157867 · Cited by 30
Wu, X., Ding, C., Liu, X., Ding, Q., Zhang, S., Wang, Y., Xin, C., Wei, H., Mao, R., Zhang, G., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135324 · Cited by 26
The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications
Karamitsos, K., Oikonomou, E. K., Theofilis, P., Ikonomidis, I., Kassi, E. N., Lambadiari, V., GIALAFOS, E. J., Tsatsaragkou, A., Mystakidi, V. C., Zisimos, K., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134606 · Cited by 32
Diabetic Foot and Fungal Infections: Etiology and Management from a Dermatologic Perspective
Gupta, A. K., Shemer, A., Economopoulos, V., & Talukder, M. (2024) · Journal of Fungi · doi:10.3390/jof10080577 · Cited by 32
Cardiovascular Disease Prevention and Therapy in Women With Type 2 Diabetes
Cocchi, C., Coppi, F., Farinetti, A., & Mattioli, A. V. (2021) · Future Cardiology · doi:10.2217/fca-2021-0011 · Cited by 27
From diabetic hyperglycemia to cerebrovascular Damage: A narrative review
Machado, R. S., Mathias, K., Joaquim, L. D. S., de Quadros, R. W., Petronilho, F. C., & Rezin, G. T. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148611 · Cited by 25
Li, Y., Yao, Z., Yue, W., Zhang, C., Gao, S., & Wang, C. (2020) · Sensors · doi:10.3390/s20061565 · Cited by 25
Post-translational modifications on glycated plasma fibrinogen: A physicochemical insight
Perween, S., Abidi, M., Faizy, A. F., & Moinuddin, M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.018 · Cited by 24
Long Non-Coding RNAs (lncRNAs) in Cardiovascular Disease Complication of Type 2 Diabetes
Ismail, N., Abdullah, N., Murad, N. A. A., Jamal, R., & Sulaiman, S. A. (2021) · Diagnostics · doi:10.3390/diagnostics11010145 · Cited by 26
Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators
García‐Vega, D., González‐Juanatey, J. R., & Eirás, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147886 · Cited by 26
Su, Z., Cao, L., Chen, H., Zhang, P., Wu, C., Lü, J., & He, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02589-4 · Cited by 23
Xiong, X., Lu, W., Qin, X., Luo, Q., & Zhou, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110218 · Cited by 22
Chen, T. V., Cuong, T. D., Quý, P. T., Bui, T. Q., Tuấn, L. V., Huế, N. V., Triet, N. T., Hồ, Đ. V., Bảo, N. C., & Nhung, N. T. A. (2022) · Chemical Papers · doi:10.1007/s11696-022-02273-2 · Cited by 25
Vasilev, G., Kabakchieva, P., Miteva, D., Batselova, H., & Velikova, T. V. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i9.738 · Cited by 23
Szydełko, J., & Matyjaszek-Matuszek, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010616 · Cited by 19
Roles of mitochondrial dynamics and mitophagy in diabetic myocardial microvascular injury
Wang, T., Wang, X., Fu, T., Ma, Y., Wang, Q., Zhang, S., Zhang, X., Zhou, H., Chang, X., & Tong, Y. (2023) · Cell Stress and Chaperones · doi:10.1007/s12192-023-01384-3 · Cited by 22
Cardiovascular risk associated with co-morbid insomnia and sleep apnoea (COMISA) in type 2 diabetics
Hein, M., Lanquart, J., Mungo, A., & Loas, G. (2022) · Sleep Science · doi:10.5935/1984-0063.20220018 · Cited by 21
Venkatesh, S., & Suzuki, C. K. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.10.004 · Cited by 20
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases
García, R. D., Asensio, J. A., Perdicaro, D. J., & Peral, M. D. L. Á. (2022) · Current Vascular Pharmacology · doi:10.2174/1570161120666220201160038 · Cited by 21
Jiang, Y., Sui, D., Li, M., Xu, H., Yu, X., Liu, J., & Yu, Q. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9003603 · Cited by 19
Kowalska, K., Wilczopolski, P., Buławska, D., Młynarska, E., Rysz, J., & Franczyk, B. (2022) · Antioxidants · doi:10.3390/antiox11122500 · Cited by 19
Lin, Z., Wang, F., Yan, Y., Jin, J., Quan, Z., Tong, H., & Du, J. (2023) · Phytotherapy Research · doi:10.1002/ptr.7901 · Cited by 19
Guo, X., Yin, T., Chen, D. S., Xu, S., Ye, R., & Zhang, Y. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230627121700 · Cited by 19
Ling, P., Shan, W., Zhai, G., Qiu, C., Liu, Y., Xu, Y., & Yang, X. (2020) · Brain and Behavior · doi:10.1002/brb3.1773 · Cited by 19
Effect of dapagliflozin on diabetic patients with cardiovascular disease via MAPK signalling pathway
Yue, Z., Li, L., Fu, H., Yin, Y., Du, B., Wang, F., Ding, Y., Liu, Y., Zhao, R., Zhang, Z., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16786 · Cited by 18
Wang, B., Yao, J.-T., Zheng, H., & Li, Q. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s297730 · Cited by 18
Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications
Benítez-Camacho, J., Ballesteros, A., Beltrán-Camacho, L., Rojas-Torres, M., Rosal‐Vela, A., Jiménez-Palomares, M., Sánchez-Gomar, I., & Durán-Ruiz, M. C. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03537-8 · Cited by 19
Diabetes in spotlight: current knowledge and perspectives of photobiomodulation utilization
Perrier, Q., Moro, C., & Lablanche, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1303638 · Cited by 18
Vidal, T., Williams, C. A., Ramoutar, U. D., & Haffizulla, F. S. (2022) · Cureus · doi:10.7759/cureus.23173 · Cited by 17
Sun, M., Wang, R., Xia, R., Xia, Z., Wu, Z., & Wang, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.949754 · Cited by 17
Ameliorative effect of taurine against diabetes and renal‑associated disorders (Review)
Baliou, S., Adamaki, M., Ιωάννου, Π., Pappa, A., Panayiotidis, M. I., Christodoulou, I., Spandidos, D. A., Kyriakopoulos, A. M., & Zoumpourlis, V. C. (2021) · Medicine International · doi:10.3892/mi.2021.3 · Cited by 18
Hu, Y., Li, Q., Zhang, L., Zhong, L., Gu, M., He, B., Qu, Q., Lao, Y., Gu, K., Zheng, B., et al. (2021) · Clinics · doi:10.6061/clinics/2021/e2502 · Cited by 17
Zhu, M., Fan, J., Guo, Y., Guo, L., Que, H.-D., Cui, B.-Y., Li, Y.-L., Guo, S., Zhang, M., Yin, Y.-L., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155557 · Cited by 16
Unraveling the Triad: Hypoxia, Oxidative Stress and Inflammation in Neurodegenerative Disorders
Dakal, T. C., Choudhary, K., Tiwari, I., Yadav, V., Maurya, P. K., & Sharma, N. K. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.06.021 · Cited by 16
Xie, X., Wu, C., Ma, C., Gao, D., Su, W., Huang, J., Deng, K., Yan, D., & Lin, H. (2024) · Expert Systems with Applications · doi:10.1016/j.eswa.2024.124702 · Cited by 17
miR-200c inhibition and catalase accelerate diabetic wound healing
D'Agostino, M., Sileno, S., Lulli, D., Luca, N. D., Scarponi, C., Teson, M., Torcinaro, A., Santa, F. D., Cirielli, C., Furgiuele, S., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-024-01113-7 · Cited by 16
Zhang, D., Lei, Y., Gao, J., Qi, F., Yan, X., Ai, K., Zhe, X., Cheng, M., Wang, M., Su, Y., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.674288 · Cited by 16
Closs, C., Ackerman, M., Masson, W. M., Lobo, M., Molinero, G., Cobo, A. L., Béliard, S., Mourre, F., Valéro, R., & Nogueira, J. P. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-022-05338-5 · Cited by 16
Ruan, Z., Yang, L., Shi, H., Yue, X., Wang, Y., Liang, M., & Hu, H. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1860022 · Cited by 15
Zhou, J., Shi, H., Ji, F., Wu, Y., Zhao, Y., Qian, J., & Ge, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002527 · Cited by 15
Wang, Y., Xu, W., Mak, I. L., Chin, W. Y., Yu, E. Y. T., Lam, C. L. K., & Wan, E. Y. F. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101999 · Cited by 15
Metagenome Investigation of Ocular Microbiota of Cataract Patients With and Without Type 2 Diabetes
Shao, Z., Shan, X., Jing, L., Wang, W., Li, W., Ren, Z., Zhang, B. N., & Huang, Y. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.6.1 · Cited by 15
Hu, J., Wang, X., Cheng, L., Dang, K., Zhu, M., Tao, X., Xu, X., Sarker, S. K., & Li, Y. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01261-8 · Cited by 15
Metadata
- Authors
- Henning, R. J.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Henning, Robert J
- ORCID
- Henning, Robert J
- Venue
- Future Cardiology
- Publisher
- Informa UK Limited
- Published
- 2018-11
- Volume
- 14
- Issue
- 6
- Pages
- 491-509
- ISSN
- 1479-6678 (ISSN-L)
- 1744-8298
- OpenAlex
- W2900050340
- Cited by
- 398
- References
- 111
- Citations by year
- 2026: 32 · 2025: 64 · 2024: 62 · 2023: 70 · 2022: 69 · 2021: 69 · 2020: 27 · 2019: 4 · 2018: 1
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Future Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, cardiovascular disease, hyperglycemia, insulin resistance, oxidative stress, advanced glycation end products, atherogenesis, vascular inflammation, tight glycemic control, metformin, SGLT2 inhibitors, DPP-4 inhibitors, coronary angioplasty, coronary stenting, coronary artery bypass grafting, acute myocardial infarction
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
